Corporis Medical's Eurostars Project “Obtain” Achieves Successful First In Vivo Test
Corporis Medical CSO Dr. Alexander Veenhof has successfully completed the first in vivo test for our latest innovation, “the miniaturized Laprixa probe”.
Corporis Medical achieves market approval in the USA for the Mediclose System
After extensive review of Corporis Medical’s 510(k) pre-market submission, the FDA has granted its approval for the Mediclose System to enter the US market!
Corporis Medical successfully concludes First-in-Human study with the Mediclose System
Led by our CSO and founder Alexander Veenhof, Corporis Medical’s Mediclose System has been validated in patients in a multicenter First-in-Human clinical investigation.
